Randy S Longman
Overview
Explore the profile of Randy S Longman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
4346
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maldarelli G, Metz M, Oguntunmibi S, Tran N, Xiang G, Lukin D, et al.
Gut Microbes
. 2025 Feb;
17(1):2464221.
PMID: 39949039
Joint inflammation is the most common extraintestinal manifestation of Crohn's disease (CD). Although alterations in the enteric microbiota are described in CD with spondyloarthritis (CD-SpA), it is not known whether...
2.
3.
Pires S, Longman R
J Exp Med
. 2024 Apr;
221(6).
PMID: 38597953
Environmental airborne antigens are central to the development of allergic asthma, but the cellular processes that trigger disease remain incompletely understood. In this report, Schmitt et al. (https://doi.org/10.1084/jem.20231236) identify TNF-like...
4.
Lima S, Pires S, Rupert A, Oguntunmibi S, Jin W, Marderstein A, et al.
Cell Rep Med
. 2024 Feb;
5(3):101431.
PMID: 38378002
Sulfasalazine is a prodrug known to be effective for the treatment of inflammatory bowel disease (IBD)-associated peripheral spondyloarthritis (pSpA), but the mechanistic role for the gut microbiome in regulating its...
5.
Hassan-Zahraee M, Ye Z, Xi L, Dushin E, Lee J, Romatowski J, et al.
J Crohns Colitis
. 2023 Dec;
18(9):1361-1370.
PMID: 38141256
Background And Aims: Ritlecitinib, an oral JAK3/TEC family kinase inhibitor, was well-tolerated and efficacious in the phase 2b VIBRATO study in participants with moderate-to-severe ulcerative colitis [UC]. The aim of...
6.
Van N, Zhang K, Wigmore R, Kennedy A, DaSilva C, Huang J, et al.
Nat Commun
. 2023 Nov;
14(1):7363.
PMID: 37963876
Environmental factors are the major contributor to the onset of immunological disorders such as ulcerative colitis. However, their identities remain unclear. Here, we discover that the amount of consumed L-Tryptophan...
7.
Kumar A, Kim E, Kozan P, Jacob V, Longman R, Scherl E, et al.
Crohns Colitis 360
. 2023 Feb;
2(4):otaa074.
PMID: 36777752
Background: Nonadherence to biologic therapy in inflammatory bowel disease (IBD) is associated with risk of relapse, immunogenicity, and disease complications. Significant nonadherence prevalence is reported with tumor necrosis factor (TNF)...
8.
Hill A, Kim M, Zegarra-Ruiz D, Chang L, Norwood K, Assie A, et al.
JCI Insight
. 2022 Dec;
8(3).
PMID: 36538527
Chronic exposure to high-fat diets (HFD) worsens intestinal disease pathology, but acute effects of HFD in tissue damage remain unclear. Here, we used short-term HFD feeding in a model of...
9.
Viladomiu M, Khounlotham M, Dogan B, Lima S, Elsaadi A, Cardakli E, et al.
Cell Rep
. 2022 Nov;
41(7):111637.
PMID: 36384110
Endoplasmic reticulum (ER) stress is associated with Crohn's disease (CD), but its impact on host-microbe interaction in disease pathogenesis is not well defined. Functional deficiency in the protein disulfide isomerase...
10.
Battat R, Scherl E, Lukin D, Charilaou P, Mahtani P, Gerber J, et al.
J Crohns Colitis
. 2022 Nov;
17(5):795-803.
PMID: 36322790
Background: Most Crohn's disease [CD] patients require surgery. Ileitis recurs after most ileocolectomies and is a critical determinant for outcomes. The impacts of ileocolectomy-induced bile acid [BA] perturbations on intestinal...